• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CT 影像学中间容积定义了一个纤维化区域,该区域可预测常染色体显性遗传多囊肾病患者肾小球滤过率下降。

Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.

机构信息

Department of Biomedical Engineering, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

出版信息

Am J Pathol. 2011 Aug;179(2):619-27. doi: 10.1016/j.ajpath.2011.04.036. Epub 2011 Jun 17.

DOI:10.1016/j.ajpath.2011.04.036
PMID:21683674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3157175/
Abstract

Total kidney and cyst volumes have been used to quantify disease progression in autosomal dominant polycystic kidney disease (ADPKD), but a causal relationship with progression to renal failure has not been demonstrated. Advanced image processing recently allowed to quantify extracystic tissue, and to identify an additional tissue component named "intermediate," appearing hypoenhanced on contrast-enhanced computed tomography (CT). The aim of this study is to provide a histological characterization of intermediate volume, investigate its relation with renal function, and provide preliminary evidence of its role in long-term prediction of functional loss. Three ADPKD patients underwent contrast-enhanced CT scans before nephrectomy. Histological samples of intermediate volume were drawn from the excised kidneys, and stained with hematoxylin and eosin and with saturated picrosirius solution for histological analysis. Intermediate volume showed major structural changes, characterized by tubular dilation and atrophy, microcysts, inflammatory cell infiltrate, vascular sclerosis, and extended peritubular interstitial fibrosis. A significant correlation (r = -0.69, P < 0.001) between relative intermediate volume and baseline renal function was found in 21 ADPKD patients. Long-term prediction of renal functional loss was investigated in an independent cohort of 13 ADPKD patients, followed for 3 to 8 years. Intermediate volume, but not total kidney or cyst volume, significantly correlated with glomerular filtration rate decline (r = -0.79, P < 0.005). These findings suggest that intermediate volume may represent a suitable surrogate marker of ADPKD progression and a novel therapeutic target.

摘要

全肾和囊肿体积已被用于量化常染色体显性多囊肾病(ADPKD)的疾病进展,但尚未证明其与肾功能衰竭进展有因果关系。先进的图像处理技术最近允许定量测量囊外组织,并识别出一种名为“中间”的额外组织成分,在对比增强 CT(CT)上呈低增强。本研究旨在提供中间体积的组织学特征描述,研究其与肾功能的关系,并初步证明其在功能丧失的长期预测中的作用。三名 ADPKD 患者在肾切除术前接受了对比增强 CT 扫描。从切除的肾脏中提取中间体积的组织样本,并进行苏木精和伊红染色以及饱和苦味酸溶液染色以进行组织学分析。中间体积显示出主要的结构变化,特征为管状扩张和萎缩、微小囊肿、炎症细胞浸润、血管硬化和广泛的肾小管间纤维化。在 21 名 ADPKD 患者中发现相对中间体积与基线肾功能之间存在显著相关性(r = -0.69,P < 0.001)。在 13 名 ADPKD 患者的独立队列中进行了肾功能丧失的长期预测研究,随访时间为 3 至 8 年。中间体积而不是全肾或囊肿体积与肾小球滤过率下降显著相关(r = -0.79,P < 0.005)。这些发现表明,中间体积可能是 ADPKD 进展的合适替代标志物和新的治疗靶点。

相似文献

1
Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.CT 影像学中间容积定义了一个纤维化区域,该区域可预测常染色体显性遗传多囊肾病患者肾小球滤过率下降。
Am J Pathol. 2011 Aug;179(2):619-27. doi: 10.1016/j.ajpath.2011.04.036. Epub 2011 Jun 17.
2
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.常染色体显性多囊肾病(ADPKD)早期的肾脏结构:多囊肾病放射影像学研究联盟(CRISP)队列
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
3
Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.通过计算机断层扫描对常染色体显性遗传性多囊肾病进展进行容积测定
Kidney Int. 2000 Dec;58(6):2492-501. doi: 10.1046/j.1523-1755.2000.00433.x.
4
Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.常染色体显性多囊肾病中尿内皮素-1与估计肾小球滤过率的关系:一项初步横断面分析
BMC Nephrol. 2016 Feb 29;17:22. doi: 10.1186/s12882-016-0232-8.
5
Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.3T磁共振成像与常染色体显性多囊肾病中的总纤维化体积
Intern Med J. 2018 Dec;48(12):1505-1513. doi: 10.1111/imj.14039.
6
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.磁共振测量肾血流量作为常染色体显性多囊肾病疾病严重程度的标志物。
Kidney Int. 2003 Dec;64(6):2214-21. doi: 10.1046/j.1523-1755.2003.00326.x.
7
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.尿血管紧张素原除影像学分类外,还可预测常染色体显性遗传性多囊肾病的肾脏结局。
J Korean Med Sci. 2020 Jun 8;35(22):e165. doi: 10.3346/jkms.2020.35.e165.
8
Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾脏、肾囊肿及肾实质体积的定量分析与纵向趋势研究
J Am Soc Nephrol. 2000 Aug;11(8):1505-1511. doi: 10.1681/ASN.V1181505.
9
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.常染色体显性遗传多囊肾病的影像学分类:一种用于选择临床试验患者的简单模型。
J Am Soc Nephrol. 2015 Jan;26(1):160-72. doi: 10.1681/ASN.2013101138. Epub 2014 Jun 5.
10
Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model.用于猫常染色体显性多囊肾病大型动物模型中疾病表现和进展的肾脏和囊肿体积成像。
BMC Nephrol. 2019 Jul 12;20(1):259. doi: 10.1186/s12882-019-1448-1.

引用本文的文献

1
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.常染色体显性多囊肾病:从发病机制到类器官疾病模型
Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766.
2
Reliability of radiomic analysis on multiparametric MRI for patients affected by autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者多参数磁共振成像的影像组学分析可靠性
Sci Rep. 2025 May 13;15(1):16526. doi: 10.1038/s41598-025-99982-x.
3
Abdominal Imaging in ADPKD: Beyond Total Kidney Volume.常染色体显性多囊肾病的腹部影像学检查:超越总肾体积
J Clin Med. 2023 Aug 5;12(15):5133. doi: 10.3390/jcm12155133.
4
Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.磁共振弥散加权成像在多囊肾病中肾囊肿体积定量和非囊组织特征分析中的应用。
Eur Radiol. 2023 Sep;33(9):6009-6019. doi: 10.1007/s00330-023-09601-4. Epub 2023 Apr 5.
5
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.基于自动实例囊肿分割的新影像衍生生物标志物在常染色体显性多囊肾病预后中的应用。
Kidney Int. 2023 Aug;104(2):334-342. doi: 10.1016/j.kint.2023.01.010. Epub 2023 Feb 1.
6
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery.用于模拟患者特异性疾病和药物发现的工程化肾小管。
EBioMedicine. 2018 Jul;33:253-268. doi: 10.1016/j.ebiom.2018.06.005. Epub 2018 Jul 3.
7
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.常染色体显性多囊肾病(ADPKD):来自改善全球肾脏病预后组织(KDIGO)争议会议的执行摘要
Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18.
8
Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.低剂量雷帕霉素(西罗莫司)对常染色体显性多囊肾病的影响:一项开放标签随机对照试验研究
Clin J Am Soc Nephrol. 2014 May;9(5):881-8. doi: 10.2215/CJN.02650313. Epub 2014 Apr 10.
9
Detected renal cysts are tips of the iceberg in adults with ADPKD.在成人 ADPKD 患者中,检测到的肾囊肿只是冰山一角。
Clin J Am Soc Nephrol. 2012 Jul;7(7):1087-93. doi: 10.2215/CJN.00900112. Epub 2012 May 10.
10
Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.RESOLVE 试验的原理和设计:兰瑞肽作为一种容积缩小治疗药物用于常染色体显性多囊肾病患者的多囊肝。
BMC Nephrol. 2012 Apr 4;13:17. doi: 10.1186/1471-2369-13-17.

本文引用的文献

1
Effects of specific genes activating RAGE on polycystic kidney disease.特定基因激活 RAGE 对多囊肾病的影响。
Am J Nephrol. 2010;32(2):169-78. doi: 10.1159/000315859. Epub 2010 Jul 6.
2
Everolimus in patients with autosomal dominant polycystic kidney disease.依维莫司治疗常染色体显性遗传多囊肾病。
N Engl J Med. 2010 Aug 26;363(9):830-40. doi: 10.1056/NEJMoa1003491. Epub 2010 Jun 26.
3
Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.实验性 Pkd1 模型和多囊肾病患者中 TGFbeta-Smad 信号的升高。
J Pathol. 2010 Sep;222(1):21-31. doi: 10.1002/path.2734.
4
Sirolimus therapy to halt the progression of ADPKD.西罗莫司治疗以阻止 ADPKD 的进展。
J Am Soc Nephrol. 2010 Jun;21(6):1031-40. doi: 10.1681/ASN.2009121302. Epub 2010 May 13.
5
Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system.维生素 D 受体通过抑制肾素-血管紧张素系统来减轻肾纤维化。
J Am Soc Nephrol. 2010 Jun;21(6):966-73. doi: 10.1681/ASN.2009080872. Epub 2010 Apr 8.
6
Improving clinical trial design for inquiries into the mechanisms of cyst growth in ADPKD.改进用于探究常染色体显性多囊肾病囊肿生长机制的临床试验设计。
Kidney Int. 2009 Jan;75(2):139-41. doi: 10.1038/ki.2008.596.
7
Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection.慢性肾脏病的当前及未来药物治疗:肾脏保护中不断演变的靶点
Nat Rev Drug Discov. 2008 Nov;7(11):936-53. doi: 10.1038/nrd2685. Epub 2008 Oct 10.
8
Clinical practice. Autosomal dominant polycystic kidney disease.临床实践。常染色体显性遗传性多囊肾病
N Engl J Med. 2008 Oct 2;359(14):1477-85. doi: 10.1056/NEJMcp0804458.
9
Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.骨膜蛋白通过αV整合素受体诱导人常染色体显性遗传性多囊肾细胞增殖。
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1463-71. doi: 10.1152/ajprenal.90266.2008. Epub 2008 Aug 27.
10
Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.计算机断层扫描评估常染色体显性多囊肾病进展:一份进展报告。
Clin J Am Soc Nephrol. 2006 Jul;1(4):754-60. doi: 10.2215/CJN.02251205. Epub 2006 Jun 14.